Michael Scolaro

Michael Scolaro

Nov 19, 2017

Group 6 Copy 204
5
Please wait...

About This Project

We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

Blast off!

Browse Other Projects on Experiment

Related Projects

Personalized Cancer and Viral Therapy: Clostridium-based Cell Delivery System coupled to CRISPR/Cas9 Nanotherapeutic

One of the fundamental weaknesses in cancer treatment or any therapy based at the cellular level is entering...

Gila monster genomics: conservation, venom, and treatments for Type-II diabetes

The Gila monster, with its distinctive black and orange pattern, is one of Arizona’s most iconic animals...

Are coyotes contributing to the spread Rocky Mountain spotted fever in Arizona?

Rocky Mountain spotted fever (RMSF) is a tick-borne bacterial infection that can cause permanent disability...

Backer Badge Funded